Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXTENZA vs Prednisolone Acetate after SMILE surgery
NCT04380857Phase 4Completed
- Start
- Jun 2020
- Primary completion
- Jun 2021
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ozurdex in postoperative pain and post-operative inflammation (2 arms). Primary endpoint: Mean Change in Pain at Day 90. Started Jun 2020; status: completed.
02
Drugs
ozurdex
03
Conditions
postoperative painpost-operative inflammation
Beyond the preview
Go deeper on NCT04380857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04380857.